Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Recurrent VTE · patients with the initial treatment of venous thromboembolism in patients with cancer

Dalteparin showed no clear difference in recurrent VTE compared with tinzaparin (low certainty).

1 finding from 1 review

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes only
RR 0.44 [0.09, 2.16]
1 study · 113 participants
Low